In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

There’s no data from a head-to-head trial directly comparing Eli Lilly and ... study has found that Lilly’s tirzepatide seems to be better at achieving weight loss. Tirzepatide – a dual ...

But there is more to the story. Viking's leading candidate, VK2735, is a potential dual GLP-1/GIP weight loss treatment that ...

The singer reflected on being ‘so broken and dark’ a year ago.